Author + information
- Received February 9, 2009
- Revision received September 8, 2009
- Accepted September 22, 2009
- Published online July 6, 2010.
- Prediman K. Shah, MD* ()
- ↵*Reprint requests and correspondence:
Dr. Prediman K. Shah, Division of Cardiology and Atherosclerosis Research Center, Cedars-Sinai Heart Institute, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Suite 5531, Los Angeles, California 90048
Unheralded vaso-occlusive cardiovascular events (myocardial infarction, sudden death, and stroke) are common manifestations of atherothrombotic vascular disease, and accurate identification of individuals at risk of such events is highly desirable. Risk factor assessment and management have been the cornerstones of preventive strategies but are constrained by less than desirable accuracy and less than optimal compliance, respectively. In selected populations, noninvasive imaging using carotid ultrasound and/or coronary calcium score can incrementally refine risk assessment and may allow for improved adherence and better matching of preventive interventions to the magnitude of risk. Further refinements in the future may also be possible with novel biomarkers and measures of plaque phenotype.
- Received February 9, 2009.
- Revision received September 8, 2009.
- Accepted September 22, 2009.
- American College of Cardiology Foundation
- Burden of Cardiovascular Disease
- Framingham Risk Score (FRS) and Cardiovascular Events: Good but Not Good Enough
- Unconditional Treatment of All: Why Bother Screening for Risk? Why Not Treat Everyone?
- Can We Detect Subclinical Atherosclerosis Noninvasively, and Does It Matter?
- Imaging of Subclinical Atherosclerosis: We Can and It Matters, but Should We?